• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconNIH

NIH

HealthHundreds of NIH scientists pen letter criticizing Trump’s deep cuts to public health research
By Calvin Woodward, Nathan Ellgren and The Associated PressJune 10, 2025
Health‘We dissent’: NIH workers protest Trump policies that ‘harm the health of Americans’
By KFF Health News and Rachana PradhanJune 9, 2025
A man outside in the snow holds a sign with rainbow lettering that reads, "Save kid's cancer research from 'DOGE' please!"
PoliticsFired NIH workers lost their ‘dream job.’ Due to a Kafkaesque appeals process and slim private-sector offerings, their futures may be in jeopardy, too
By Sasha RogelbergMarch 10, 2025
People clink wine glasses at a dinner party
HealthThe dangers of drinking: Experts explain the 4 ways alcohol can cause cancer
By Lindsey LeakeFebruary 21, 2025
A woman takes pills at her desk
HealthThe dietary supplements you think are improving your health may be damaging your liver, research warns
By Lindsey LeakeFebruary 18, 2025
An older man wearing a business suit holds a pill in one hand and a glass of water in the other.
HealthThe aspirin mistake: 29 million take it daily, not realizing costs outweigh benefits
By Lindsey LeakeFebruary 3, 2025
Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication in the works that could be approved by the FDA as early as 2026, CEO Dave Ricks told Bloomberg TV on Jan. 13, 2025.
HealthHate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says
By Lindsey LeakeJanuary 21, 2025
Moderna is recruiting adult participants for Nova 301, its Phase 3 clinical trial evaluating an investigational norovirus vaccine called mRNA-1403.
HealthModerna says it’s ‘one step closer’ to a norovirus vaccine as the virus spreads across the U.S.
By Lindsey LeakeJanuary 11, 2025
Lynparza (olaparib), a product of Fortune 500 pharmaceutical firm Merck and Fortune 500 Europe company AstraZeneca, showed meaningful improvements in overall survival in people with germline BRCA-mutated (gBRCAm), HER2-negative high-risk early breast cancer, 2024 clinical trial data suggest.
HealthMerck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows
By Lindsey LeakeDecember 20, 2024
Group of people pouring Champagne into glasses
HealthJust one alcoholic drink a day can increase your risk of cancer. But most Americans don’t know the dangers, new survey says
By Lindsey LeakeDecember 5, 2024
A senior woman measures her blood pressure at home
HealthHypertension is a ‘silent killer.’ Here’s what your blood pressure should be at every age
By Lindsey LeakeNovember 25, 2024
Compared to other exercise patterns studied, peak physical activity in both the morning and evening was associated with an 11% lower risk of colorectal cancer, according to research published in September 2024 in the journal BMC Medicine.
HealthWorking out at these times of day could reduce your risk of colorectal cancer by 11%, new study says
By Lindsey LeakeNovember 11, 2024
In 2024, rapid COVID tests are a staple of cough-and-cold aisles across America. But the convenience of self-testing comes with a caveat: The onus is on you to report your results.
Health54 million COVID cases went unreported in 2022, study says. Here’s how to make your at-home test count
By Lindsey LeakeOctober 9, 2024
MeAgainMeds.com, a free tool developed by researchers at the George Mason University College of Public Health in Fairfax, Va., uses AI to pair people with depression with the best available antidepressant medication for them.
MindAntidepressant not working? AI may do a better job than your doctor in matching you with the best medicine
By Lindsey LeakeAugust 14, 2024
New research published in the Journal of the American Heart Association suggests the mere recollection of a time you were angry may be harmful to your heart.
HealthWhen’s the last time you were angry? Just recalling the experience may be detrimental to your heart health, study says
By Lindsey LeakeJune 1, 2024
1
  • 1
  • 2
  • 3
3
Most Popular
Magazine
The youngest-ever female CEO of a Fortune 500 company is fighting Trump's cuts to keep Medicaid strongAn image of a popular article
By Fortune EditorsMarch 24, 2026
Commentary
The Treasury just declared the U.S. insolvent. The media missed itAn image of a popular article
By Fortune EditorsMarch 23, 2026
Success
Palantir’s billionaire CEO says only two kinds of people will succeed in the AI era: trade workers — ‘or you’re neurodivergent’An image of a popular article
By Fortune EditorsMarch 24, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.